FDA 483 - Autolus Limited

An FDA inspection of Autolus Limited (The Nucleus) in Stevenage, United Kingdom, a drug substance and drug product manufacturer, revealed significant deficiencies. Observations included incomplete validation of critical manufacturing processes and equipment, inadequate validation and monitoring of critical utilities, and insufficient disinfectant studies to prevent cross-contamination. These issues indicate a lack of assurance in product quality and control.